Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 29, Issue 1, Pages 127-134
Publisher
Springer Science and Business Media LLC
Online
2023-01-17
DOI
10.1038/s41591-022-02115-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer
- (2022) Jeanne Tie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA)
- (2021) Emily A. Verbus et al. ANNALS OF SURGICAL ONCOLOGY
- CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer
- (2021) Hiroya Taniguchi et al. CANCER SCIENCE
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
- (2021) T. Yoshino et al. ANNALS OF ONCOLOGY
- ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
- (2021) Thomas Powles et al. NATURE
- Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
- (2021) Eiji Oki et al. Annals of Gastroenterological Surgery
- The effect of surgical trauma on circulating free DNA levels in cancer patients – implications for studies of circulating tumor DNA
- (2020) Tenna V. Henriksen et al. Molecular Oncology
- A new prognostic and predictive tool for shared decision making in stage III colon cancer
- (2020) Alberto F. Sobrero et al. EUROPEAN JOURNAL OF CANCER
- Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
- (2019) R. Charles Coombes et al. CLINICAL CANCER RESEARCH
- Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer
- (2019) Yuxuan Wang et al. JAMA Oncology
- Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
- (2019) Thomas Reinert et al. JAMA Oncology
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
- (2019) Jeanne Tie et al. JAMA Oncology
- Adjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysis
- (2016) Giovanni Brandi WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases
- (2016) Emily Khoo et al. HPB
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Path Toward Prognostication and Prediction: An Evolving Matrix
- (2011) Al B. Benson et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search